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Barbara J. Fletcher, RN, MN,z Nancy Houston Miller, RN, BSNxC ardiovascular disease (CVD) is a major causeof morbidity and premature mortality inwomen and men worldwide. During the
past 2 decades, the prevalence of CVD and stroke
has increased and accelerated in low- and middle-
income countries that currently bear the major
burden of these chronic conditions (1,2). Although a
myriad of both modiﬁable and immutable factors
contribute to the worldwide epidemic of CVD and
stroke, accumulated data clearly underscore the
important role of life course prevention.
Twelve million nurses form the largest health care
discipline managing CVD risk factors and chronic
disease globally (3). The American Heart Association
(AHA) and the World Health Organization recognize
the key role that nurses and other team members play
in supporting the goal to reduce death and disability
from CVD by 25% in 2025 (4,5). For more than 4 de-
cades, nurses and advanced practice nurses have
taken on key roles in managing single and multiple
risk factors, including hypertension, smoking, lipids,
and diabetes; the sequelae of chronic conditions,assachusetts, and the
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b and Pﬁzer.such as coronary artery disease and heart failure,
through specialized clinics; and programs in primary
care, worksites, and cardiac rehabilitation (6–17). By
taking on a primary role as team leaders in providing
case management, nurses have proven their capa-
bility to not only reduce CVD risk factors, but to also
adhere to treatment guidelines and protocols,
decrease hospitalization, and reduce morbidity and
mortality in those with established disease. Such
programs demonstrating improved outcomes and
cost effectiveness have been noted in both devel-
oping and developed countries (7,18,19) (Table 1).
Compelling data exist that support the role of
nursing in CVD and stroke prevention (4). In the early
1990s, the SCRIP (Stanford Coronary Risk Interven-
tion Project) trial demonstrated that nurse-led risk
reduction for patients with known CVD resulted in
angiographically documented regression of disease
and a reduction in clinical events (10). Following this
landmark study, numerous clinical trials have docu-
mented the important and effective role of nurses in
improving adherence to guideline-based medical
therapies and lifestyle change (6–11). The Cardiac
Hospitalization Atherosclerosis Management Program
showed, in patients hospitalized with coronary
artery disease, a signiﬁcant reduction in morbidity
and mortality (p < 0.05) after 1 year following
discharge for those who received nurse-directed
case management compared with usual care (17).
EUROACTION demonstrated that CVD adherence to
guideline recommendations for the primary and sec-
ondary prevention of CVD could be improved with
TABLE 1 Nurse Case Management Trials—Summary of Findings
Nursing Intervention Signiﬁcant Outcomes
Optimize management of dyslipidemia Improved measures of dyslipidemia
CVD risk reduction: lifestyle (diet and exercise) 10-year CVD risk reduction
Hypertension (5 E program: Education,
Engagement, Environment,
Evidence, Evaluation)
Blood pressure, BMI, and weight reduction
Diabetes and hypertension Blood pressure and diabetes improved
Smoking cessation (education,
counseling, and follow-up)
Signiﬁcant “quit” rate
CVD risk with medication counseling
and management
Less CAD progression; all CVD risk factors
lowered; decreased Framingham score
CVD risk management cost evaluation Cost effective
Data from Berra et al. (16).
BMI ¼ body mass index; CAD ¼ coronary artery disease; CVD ¼ cardiovascular disease.
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865nurse-directed teams located at hospitals, clinics, and
community centers. Their efforts were focused on
individuals, families, and communities (11).
Recognizing the individual and collective contri-
butions that nurses have made in CVD and stroke
prevention and the promise of empowering nurses as
global cardiovascular leaders, the Preventive Cardio-
vascular Nurses Association (PCNA) initiated the
Global Cardiovascular Nursing Leadership Forum
(GCNLF). The GCNLF is designed to champion a
global nursing movement for CVD and stroke pre-
vention across the lifespan of individuals and families
from both developed and developing countries. The
inaugural (phase I) meeting was held in New York,
New York, in October 2014, and included nurse
leaders from Africa, Australia, China, South America,
the Philippines, the Middle East, the European Union,
the United Kingdom, and the United States. Consis-
tent with the mission and goals of the GCNLF, a major
focus of this meeting was to explore ways in which
nursing and global nurse organizations could support
the cardiovascular risk and stroke reduction goal set
by the World Heart Federation, and reafﬁrmed by the
AHA, to reduce noncommunicable disease (NCD)
mortality by 25% by 2025 (4,5). Keynote addresses at
the inaugural meeting were delivered by Dr. Valentin
Fuster, Director of Mount Sinai Heart, and by Dr.
Martha Hill, Dean Emerita and Professor of Nursing,
Johns Hopkins University. With internationally
recognized expertise in prevention, management,
and control of global CVD and stroke, Drs. Fuster and
Hill both emphasized the importance of multidisci-
plinary, multisectorial efforts designed to reduce the
risk and burden of CVD, particularly in low- and
middle-income countries.
Dr. Fuster highlighted elements of the Institute of
Medicine report “Promoting Cardiovascular Health in
the Developing World,” demonstrating the burden of
CVD in low- and middle-income countries, as well as
the need for and beneﬁts of multilevel prevention
efforts, beginning early in life and extending across
the life course (1). In summarizing both ongoing and
completed research by assembled multidisciplinary
global teams, Dr. Fuster illustrated the importance of
basic and translational research designed to prevent
and treat CVD and stroke. Outcomes of recent work
conducted in Bogotá (20) and Spain (21), as well as
research in progress in Kenya (22), illustrated the
importance of training of health care professionals in
CVD prevention, as well as the potential for multi-
level interventions in reducing major risk factors for
CVD and stroke in children, adults, and families from
diverse communities. Dr. Fuster concluded his
address with “a call to action” emphasizing potentialroles for nurses and nursing in practice, research, and
advocacy relevant to CVD and stroke prevention.
Dr. Hill reafﬁrmed Dr. Fuster’s comments on the
magnitude of the global burden of CVD and provided
speciﬁcs on the rationale for focus on low- and
middle-income countries, as well as developed
countries. She highlighted global health care chal-
lenges, including geographic and economic differ-
ences between rural and urban environments, the
widening gap between rich and poor (within and
among countries), the current domestic unrest and
political strife with emerging governments, and the
effect of geopolitical, social, and ﬁscal factors on
health policies that affect CVD prevention efforts. As
deterrents to global CVD prevention efforts, Dr. Hill
also emphasized the shortage of nurses and other
health care professionals, as well as barriers to
treatment related to patients, providers, and health
care organizations. In addressing the optimal role of
nurses and nursing in CVD prevention, Dr. Hill
emphasized the importance of patient-centered care,
evidence-based practice, and quality improvement
initiatives; the use of information technology; and
effective functioning of nurses as part of interdisci-
plinary teams. Global opportunities suggested for
nurses and nursing were passionately proposed by
Dr. Hill including methods and approaches to:
1) enhance the quality of health care services across
settings; 2) improve health systems; 3) remove barriers
to high-quality care; 4) reduce health care disparities;
5) analyze issues in health care from a global perspec-
tive; and 6) take nursing from a local to a global level.
Finally, Dr. Hill recommended innovative approaches
to effective solutions with an emphasis on creating
partnerships to align stakeholder resources, increasing
nursing’s capacity and diversity, and redesigning
nursing education and practice to optimize preven-
tion. She concluded her “call to action” with the need
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866for nursing leaders who champion the global CVD
prevention efforts to be competent, credible, creden-
tialed, committed, and skilled communicators.
Following the keynote addresses, CVD nurse
leaders presented information on the burden of CVD
in their respective countries and regions, providing
an update on the status of nursing involvement in
ongoing and planned CVD and stroke prevention
efforts. Individual work groups composed of nurse
leaders and the PCNA Board of Directors addressed
the challenges and opportunities for nursing in global
CVD and stroke prevention. These discussions
included ways to optimize and enhance nursing’s
unique and collaborative contributions to the goals of
the World Heart Federation and AHA.
Building on work accomplished in phase I of the
GCNLF and earlier work championed and accom-
plished by PCNA (8,13,16,23–25) (in collaboration with
the Council on Cardiovascular Nursing and Allied
Professions and the Council on Cardiovascular and
Stroke Nursing), short-term goals and activities
include developing a global nursing website designedto: 1) house links to educational resources and archive
on-demand courses in CVD risk reduction and stroke
prevention (available in several languages); 2) pro-
vide access to U.S. and international evidence-based
guidelines; and 3) provide access to a registry of
CVD and stroke prevention nurse experts. The GCNLF
is also initiating a master plan for international
nursing organizations to identify and facilitate
optimal ways in which nurses and nursing organiza-
tions can be more effective in CVD and stroke
prevention worldwide. By design, this includes
enhancing the recognition of the central role that
nurses play in the global ﬁght against NCDs. Our long-
term goals are to elevate the role of cardiovascular
and stroke nursing globally and to affect CVD pre-
vention and treatment around the world. Phase II is
planned for fall 2015.
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